Management guidelines continue to identify metformin as initial pharmacologic antidiabetic therapy of choice for people with type 2 diabetes without contraindications, despite recent randomized trials that have demonstrated significant improvements in cardiovascular outcomes with newer classes of an...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!